NYSE:TGX - Theragenics Stock Price, Price Target & More

$0.0050 0.00 (0.00 %)
(As of 04/25/2018 03:00 AM ET)
Previous Close$0.0050
Today's Range$0.0050 - $0.0050
52-Week RangeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

About Theragenics (NYSE:TGX)

Theragenics Corporation is a medical device company serving the surgical products and cancer treatment markets. The Company operates in two business segments: surgical products segment and brachytherapy seed segment. The Company's surgical products business manufactures, markets and sells disposable devices primarily utilized in certain surgical procedures. The Company's brachytherapy seed business manufactures, markets and sells radioactive seeds primarily utilized in the treatment of early stage prostate cancer. The Company designs , manufactures, assembles, packages and distributes its surgical products in three primary production facilities, each of which manufactures different products. In October 2013, the Company announced that it has completed the merger with Juniper Acquisition Corporation.

Receive TGX News and Ratings via Email

Sign-up to receive the latest news and ratings for TGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding SharesN/A

How to Become a New Pot Stock Millionaire

Theragenics (NYSE:TGX) Frequently Asked Questions

What is Theragenics' stock symbol?

Theragenics trades on the New York Stock Exchange (NYSE) under the ticker symbol "TGX."

Has Theragenics been receiving favorable news coverage?

News coverage about TGX stock has trended positive this week, Accern Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Theragenics earned a coverage optimism score of 0.35 on Accern's scale. They also gave news stories about the medical device company an impact score of 48.19 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

How do I buy shares of Theragenics?

Shares of TGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Theragenics' stock price today?

One share of TGX stock can currently be purchased for approximately $0.0050.

How can I contact Theragenics?

Theragenics' mailing address is 5203 Bristol Industrial Way, BUFORD, GA 30518, United States. The medical device company can be reached via phone at +1-770-8315137.

MarketBeat Community Rating for Theragenics (TGX)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  58
MarketBeat's community ratings are surveys of what our community members think about Theragenics and other stocks. Vote "Outperform" if you believe TGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TGX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Theragenics (NYSE:TGX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/25/2016 forward)


Theragenics (NYSE:TGX) Earnings History and Estimates Chart

Earnings by Quarter for Theragenics (NYSE:TGX)

Theragenics (NYSE TGX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2013Q2 2013$0.03$21.96 million$20.30 millionViewN/AView Earnings Details
2/14/2013Q4 2012($0.01)$19.88 million$19.10 millionViewListenView Earnings Details
11/8/2012Q312$0.02$20.50 million$19.92 millionViewN/AView Earnings Details
8/9/2012Q2 2012$0.02ViewN/AView Earnings Details
5/10/2012Q1 2012$0.03ViewN/AView Earnings Details
2/23/2012Q4 2011$0.01ViewN/AView Earnings Details
11/3/2011Q3 2011$0.02$0.03ViewN/AView Earnings Details
8/11/2011Q2 2011$0.01$0.04ViewN/AView Earnings Details
5/5/2011Q1 2011$0.01$0.02ViewN/AView Earnings Details
2/15/2011Q4 2010$0.03ViewN/AView Earnings Details
11/9/2010Q3 2010$0.03$0.03ViewN/AView Earnings Details
8/10/2010Q2 2010$0.01$0.02ViewN/AView Earnings Details
5/4/2010Q1 2010$0.01$0.02ViewN/AView Earnings Details
2/11/2010Q4 2009$0.01ViewN/AView Earnings Details
11/5/2009Q3 2009$0.02ViewN/AView Earnings Details
8/6/2009Q2 2009$0.04ViewN/AView Earnings Details
5/7/2009Q1 2009$0.02ViewN/AView Earnings Details
2/19/2009Q4 2008$0.01ViewN/AView Earnings Details
10/30/2008Q3 2008$0.03ViewN/AView Earnings Details
7/31/2008Q2 2008$0.05ViewN/AView Earnings Details
5/1/2008Q1 2008$0.05ViewN/AView Earnings Details
2/7/2008Q4 2007$0.03ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Theragenics (NYSE:TGX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Theragenics (NYSE TGX) Insider Trading and Institutional Ownership History

Insider Trading History for Theragenics (NYSE:TGX)

Theragenics (NYSE TGX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)


Theragenics (NYSE TGX) News Headlines

No headlines for this company have been tracked by MarketBeat.com

SEC Filings

Theragenics (NYSE:TGX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Theragenics (NYSE:TGX) Income Statement, Balance Sheet and Cash Flow Statement


Theragenics (NYSE TGX) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.